Curated Business & Technology News from Around the Internet
FEATURED
Bank of America Downgrades Novavax to Underperform, Citing Long-Term Growth Concerns
Bank of America downgraded Novavax to Underperform and reduced its price target to $7, highlighting concerns about the company's ability to sustain growth amid shifting vaccine demand and stricter FDA …